These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3892332)

  • 1. Miscibility of short- and intermediate-acting insulins.
    Heine RJ
    Neth J Med; 1985; 28 Suppl 1():12-4. PubMed ID: 3892332
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of intermediate-acting insulins: tracer studies.
    Thorsteinsson B; Pramming S; Lauritzen T; Binder C
    Neth J Med; 1985; 28 Suppl 1():29. PubMed ID: 3892335
    [No Abstract]   [Full Text] [Related]  

  • 3. Kinetics of intermediate-acting insulins: clamp studies.
    Bilo HJ; Heine RJ; Sikkenk AC; van der Meer J; van der Veen EA
    Neth J Med; 1985; 28 Suppl 1():55-6. PubMed ID: 3892342
    [No Abstract]   [Full Text] [Related]  

  • 4. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.
    Peterson GE
    Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advances in insulin treatment. Evaluation of isophane or lente insulin, mixed with rapid insulin and injected twice-a-day].
    Cucinotta D; Lunetta M
    Minerva Endocrinol; 1990; 15(2):111-6. PubMed ID: 2098651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of type II diabetes using homologous intermediate-acting insulin combinations. Comparison of the effectiveness of 5 commonly used preparations].
    Haupt E; Hoppe FU; Rudolf R; Bamberg E
    Dtsch Med Wochenschr; 1987 Jul; 112(31-32):1209-12. PubMed ID: 3301260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinations of oral hypoglycemic drugs in obese, insulin-resistant diabetics.
    Fineberg SK
    Geriatrics; 1968 Sep; 23(9):137-46. PubMed ID: 5673663
    [No Abstract]   [Full Text] [Related]  

  • 8. [New insulins in diabetes therapy].
    Morell B
    Schweiz Med Wochenschr; 1979 Mar; 109(10):362-5. PubMed ID: 570723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin therapy in cats with diabetes mellitus.
    Moise NS; Reimers TJ
    J Am Vet Med Assoc; 1983 Jan; 182(2):158-64. PubMed ID: 6298164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and miscibility of 4 highly purified porcine insulins: a study in vitro and in healthy volunteers.
    Heine RJ; Van der Stap H; Salemink PJ; Kolkman-Roodbeen JC; Banken P; Gribnau TC; van der Veen EA
    Diabetes Res; 1987 Jan; 4(1):45-50. PubMed ID: 3552367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of heat on insulin absorption: different effects on amorphous and soluble insulins.
    Koivisto VA
    Acta Diabetol Lat; 1983; 20(2):175-8. PubMed ID: 6349204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-peptide antibodies induced by bovine insulin therapy.
    Reeves WG; Douglas CA
    Clin Exp Immunol; 1982 Oct; 50(1):171-7. PubMed ID: 6756729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experiences in the treatment of diabetes with insulins of monocomponent (MC) and monospecies (MS) type].
    Andreani D; Iavicoli M; Colletti A; Menzinger G
    Folia Endocrinol; 1972 Dec; 25(6):516-39. PubMed ID: 4581824
    [No Abstract]   [Full Text] [Related]  

  • 14. Intermediate-acting insulin preparations: NPH and lente.
    Deckert T
    Diabetes Care; 1980; 3(5):623-6. PubMed ID: 7192205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
    Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption kinetics and action profiles of mixtures of short- and intermediate-acting insulins.
    Heine RJ; Bilo HJ; Fonk T; van der Veen EA; van der Meer J
    Diabetologia; 1984 Dec; 27(6):558-62. PubMed ID: 6397384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of juvenile diabetes mellitus: usefulness of 24-hour fractional quantitative urine glucose.
    Forman BH; Goldstein PS; Genel M
    Pediatrics; 1974 Feb; 53(2):257-63. PubMed ID: 4812010
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-acting insulin analogs: progressing slowly].
    Holleman F; Hoekstra JB
    Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1668-9. PubMed ID: 15453117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis.
    Monami M; Marchionni N; Mannucci E
    Diabetes Res Clin Pract; 2008 Aug; 81(2):184-9. PubMed ID: 18495286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behaviour of insulin antibodies in diabetics treated with different insulins.
    Mincu I; Cheţa D; Ionescu-Tîrgovişte C; Mirodon Z; Sîntu E
    Med Interne; 1980; 18(4):347-52. PubMed ID: 7006044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.